RetroSearch Browse

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/33635541/ below:

Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures

. 2021 Jun 15;127(12):2111-2121. doi: 10.1002/cncr.33460. Epub 2021 Feb 26. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures

Affiliations

¹ Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
² Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

PMID: 33635541
PMCID: PMC8013451
DOI: 10.1002/cncr.33460

Item in Clipboard

Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures

Sarah J Nyante et al. Cancer. 2021.

. 2021 Jun 15;127(12):2111-2121. doi: 10.1002/cncr.33460. Epub 2021 Feb 26. Affiliations

¹ Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
² Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

PMID: 33635541
PMCID: PMC8013451
DOI: 10.1002/cncr.33460

Item in Clipboard

Abstract

Background: To understand how health care delays may affect breast cancer detection, the authors quantified changes in breast-related preventive and diagnostic care during the coronavirus disease 2019 (COVID-19) pandemic.

Methods: Eligible women (N = 39,444) were aged ≥18 years and received a screening mammogram, diagnostic mammogram, or breast biopsy between January 1, 2019 and September 30, 2020, at 7 academic and community breast imaging facilities in North Carolina. Changes in the number of mammography or breast biopsy examinations after March 3, 2020 (the first COVID-19 diagnosis in North Carolina) were evaluated and compared with the expected numbers based on trends between January 1, 2019 and March 2, 2020. Changes in the predicted mean monthly number of examinations were estimated using interrupted time series models. Differences in patient characteristics were tested using least squares means regression.

Results: Fewer examinations than expected were received after the pandemic's onset. Maximum reductions occurred in March 2020 for screening mammography (-85.1%; 95% CI, -100.0%, -70.0%) and diagnostic mammography (-48.9%; 95% CI, -71.7%, -26.2%) and in May 2020 for biopsies (-40.9%; 95% CI, -57.6%, -24.3%). The deficit decreased gradually, with no significant difference between observed and expected numbers by July 2020 (diagnostic mammography) and August 2020 (screening mammography and biopsy). Several months after the pandemic's onset, women who were receiving care had higher predicted breast cancer risk (screening mammography, P < .001) and more commonly lacked insurance (diagnostic mammography, P < .001; biopsy, P < .001) compared with the prepandemic population.

Conclusions: Pandemic-associated deficits in the number of breast examinations decreased over time. Utilization differed by breast cancer risk and insurance status, but not by age or race/ethnicity. Long-term studies are needed to clarify the contribution of these trends to breast cancer disparities.

Keywords: biopsy; coronavirus disease 2019 (COVID-19); interrupted time series analysis; mammography; screening.

PubMed Disclaimer

Conflict of interest statement

The authors made no disclosures.

Figures
Figure 1

Monthly change in breast screening…

Figure 1

Monthly change in breast screening and diagnostic procedures after the onset of the…

Figure 1

Monthly change in breast screening and diagnostic procedures after the onset of the COVID‐19 pandemic. The predicted mean numbers of examinations for (A) all mammograms, (B) screening mammograms, (C) diagnostic mammograms, and (D) breast biopsies conducted among participants at a subset of Carolina Mammography Registry imaging facilities were estimated using interrupted time series models. For each month after the onset of the pandemic (through September 30, 2020), the percentage change estimate compares the observed predicted mean with the expected predicted mean. Vertical lines within the histogram bars denote the 95% CIs for each estimated proportion.

Figure 2

Trends in screening mammography, diagnostic…

Figure 2

Trends in screening mammography, diagnostic mammography, and breast biopsy before and during the…

Figure 2

Trends in screening mammography, diagnostic mammography, and breast biopsy before and during the coronavirus disease 19 (COVID‐19) pandemic are illustrated. Time series plots show expected (solid red line) and observed (solid blue line) trends in (A) screening mammography, (B) diagnostic mammography, and (C) and breast biopsy between January 1, 2019 and September 30, 2020. The number of examinations is indicated on the y‐axis, and calendar time is indicated on the x‐axis. The expected number of examinations was modeled based on the preintervention trend (before March 3, 2020; denoted by the vertical line). The dotted lines around the observed number of examinations indicate 95% confidence bands.